This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Pompe disease is a rare, life-threatening genetic disorder caused by GAA enzyme deficiency, leading to glycogen buildup and muscle cell destruction. It presents on a spectrum, from infantile-onset…
NEW YORK (Reuters Health) – Standard echocardiography will confirm or exclude a patent foramen ovale (PFO) in most children, without the need for transesophageal echocardiography (TEE), clinicians from…
NEW YORK (Reuters Health) – Adults who are admitted to the hospital solely because of an acute bout of dizziness are three times more likely to suffer a…
NEW YORK (Reuters Health) – The most effective way to prevent a first stroke is not well established – what works for the primary prevention of myocardial infarction…
NEW YORK (Reuters Health) – Intravenous immunoglobulin (IVIG) offers advantages over plasma exchange (PLEX) for many patients with myasthenia gravis, according to a report online in the November…
NEW YORK (Reuters Health) – Hypothermia and the medications used with it can influence the common predictors of neurologic outcome after cardiac arrest, according to findings published online…
NEW YORK (Reuters Health) – Patients with acute migraine who find sumatriptan ineffective may have a better response to rizatriptan, according to a study reported in Cephalalgia online…
NEW YORK (Reuters Health) – White matter (WM) hyperintensities seen on MRI brain scans correlate with gait and stability difficulties in elderly subjects, as well as with reduced…
NEW YORK (Reuters Health) – The school performance at age 16 of children born to epileptic mothers correlates with their degree of exposure to anticonvulsant drugs in utero,…
NEW YORK (Reuters Health) – Forget those headlines from the past few years linking hypercholesterolemia in midlife to risk of dementia in old age. Data presented in the…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitors gefitinib or erlotinib may slow the development of central nervous system metastases in patients with advanced non-small cell lung…
